1988
DOI: 10.3109/01902148809062850
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary Macrophages Are Attracted to Inhaled Particles through Complement Activation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
33
0
1

Year Published

1991
1991
2021
2021

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 88 publications
(34 citation statements)
references
References 20 publications
0
33
0
1
Order By: Relevance
“…44 AMs have previously been shown to migrate toward complement component C5a. 28,45,46 We therefore chose the zymosan-activated FBS (a rich source of C5a) method to measure migratory capacity. We observed that the migratory capacity of AMs did not significantly change at 1 or 5 days after the 24-hour treatment with MWCNT-0.6 μm; however, at 1 and 5 days after treatment with MWCNT-20 μm, AM migratory capacity was markedly decreased.…”
Section: Discussionmentioning
confidence: 99%
“…44 AMs have previously been shown to migrate toward complement component C5a. 28,45,46 We therefore chose the zymosan-activated FBS (a rich source of C5a) method to measure migratory capacity. We observed that the migratory capacity of AMs did not significantly change at 1 or 5 days after the 24-hour treatment with MWCNT-0.6 μm; however, at 1 and 5 days after treatment with MWCNT-20 μm, AM migratory capacity was markedly decreased.…”
Section: Discussionmentioning
confidence: 99%
“…Carbon black was used in an additional group because it consists also ofultrafine particles yet has a much higher potency than TiO2 to induce in vitro chemotactic serum factors (7). These factors may be potentially important in vivo to facilitate AM particle encounter (8). The dose-response study consisted ofthe groups and intratracheal doses listed in Table 2.…”
Section: Methodsmentioning
confidence: 99%
“…21 Inhalation studies of normal and emphysematous rats revealed no pulmonary toxicity of MSHA. 17 MSHA also has been used as a negative control particle in a number of in vitro studies, including studies on pulmonary macrophage activation by complement, 22 activation of human bronchial epithelial cells, 23 and induction of the lung myofibroblast PDGF receptor system. 24 These results concur with previous findings that characterize MSHA as benign.…”
Section: Discussionmentioning
confidence: 99%